Financial Accounting and Projections for Startups

This webinar will provide an overview of financial accounting for early stage ventures. The interactive session will focus on financial skills that are most needed for startups, such as developing profit and loss statements and understanding cash flow projections.  

Requests for accommodations can be made when you register to attend. Please provide at least 7 days advance notice.

Speaker Bio

Shahram Hejazi, Ph.D., is a life science investor and entrepreneur with general management experience in both early-stage ventures and large global companies. Over his 25+ year career, Shahram has founded and/or directed the growth of more than two dozen startup companies. Currently as a Partner with BioAdvance (a venture capital firm in Philadelphia), he is responsible for leading investments in medical devices, diagnostics, digital health, and research tools. His Board responsibilities include Halo Labs Inc., Cohero Health Inc., WellTrackOne Inc., Bainbridge Health Inc., Oncora Health Inc., Talex Medical LLC, WellSheet Inc. and Keriton Inc. In addition to his current board responsibilities at BioAdvance, he is also the Chairman of the advisory board of Integral Molecular Inc., and the Chairman of Pediatric Device Consortium fund at CHOP. He is also the founder and CEO of Optimeos Life Sciences, Inc., a venture funded biotech company.

Shahram joined Princeton University in 2014 as the James Wei Visiting Professor of Entrepreneurship and has been a faculty member since then teaching two courses on the topics of complex enterprises in regulated markets and venture capital. Previously, Shahram was the president of Kodak’s life science division, where he had global responsibility for R&D, manufacturing, operations, sales, marketing, and service. Before Kodak, he was the founding CEO of Zargis Medical Corporation (a Siemens’ spin off), where he led the company’s efforts in areas ranging from raising capital and technology development to completion of several clinical trials, FDA approval, and product launch. The company was later sold to 3M. Prior to that, Shahram was the Global Head of the Strategic Business Development at Siemens Medical, responsible for identifying growth/investment opportunities and new business development in life sciences and digital health. While there, he was instrumental in establishing the Siemens corporate medical venture unit.

Earlier in his career, Shahram held R&D management positions within the imaging and nanotechnology fields at Kodak and IBM. His Past board responsibilities include FDA industry advisory panel member for Molecular and Clinical Genetic Devices, Fox Chase Cancer Center Fund, and Alpha Innotech Corp (Nasdaq: APNO). Shahram has a Ph.D. in electrical engineering with emphasis in biophysics (SUNY at Buffalo) and an executive business education (Stanford University).

Who can attend?

This event is open to 2020 eLab, Jumpstarter, PSIP, and Tiger Challenge students.